Filing Details

Accession Number:
0001179110-20-010226
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-05 16:17:09
Reporting Period:
2020-10-01
Accepted Time:
2020-10-05 16:17:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597264 Blueprint Medicines Corp BPMC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1639935 Nicholas Lydon C/o Blueprint Medicines Corporation
45 Sidney Street
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-10-01 3,896 $93.68 43,344 No 4 S Direct
Common Stock Disposition 2020-10-01 4,530 $92.88 38,814 No 4 S Direct
Common Stock Disposition 2020-10-01 1,389 $92.06 37,425 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Effected pursuant to a trading plan adopted on February 27, 2020 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.36 to $94.35 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.39 to $93.35 per share.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.89 to $92.24 per share.